In August 2024, Canada launched a PFAS data collection initiative under the Chemicals Management Plan. Companies handling listed PFAS in 2023 must report details—including quantities and product use—by January 29, 2025. Cosmetics and packaging containing PFAS may fall under the scope.

In the U.S., over-the-counter (OTC) drugs must include a standardized Drug Facts label—required by the FDA—to ensure clarity, safety, and informed consumer use. BIORIUS supports cosmetic and personal care brands by reviewing formulas and preparing compliant Drug Facts for various OTC categories, from sunscreen to oral care.

On June 24, 2024, the European Commission notified the “Omnibus VII” regulation to the WTO. Expected for adoption in Q3 2025, it bans two CMR-classified ingredients used in cosmetics—Dimethyltolylamine and TPO—from September 1, 2025. Products containing them must be removed from the EU market by this date.

May 2024: BIORIUS Information Letter 128: Update of the Canada Cosmetic Ingredient Hotlist   Health Canada has updated the Canada Cosmetic Ingredient Hotlist. It includes…

May 2024: Navigating the Path to Safe and Legal Cosmetics in the U.S. Market When it comes to entering the lucrative U.S. cosmetics market, one…

UK Responsible Person Home Legal Representation UK Responsible Person Looking for a UK cosmetics Responsible Person ? Founded in 2008, Biorius serves as the Responsible…